Raman Microscopic Study of Cervical Epithelial Cells with Subcellular Resolution

Raman Microscopic Study of Cervical Epithelial Cells with Subcellular Resolution: Comparison

Please note this is a comparison between Version 2 by Rita Xu and Version 1 by Katarzyna Sitarz.

Using Raman microscopy, we investigated epithelial cervical cells collected from 96 women with squamous cell carcinoma (SCC) or belonging to groups I, IIa, IIID-1 and IIID-2 according to Munich III classification (IIID-1 and IIID-2 corresponding to Bethesda LSIL and HSIL groups, respectively). All women were tested for human papillomavirus (HPV) infection using PCR. Subcellular resolution of Raman microscopy enabled to understand phenotypic differences in a heterogeneous population of cervical cells in the following groups: I/HPV−, IIa/HPV−, IIa/HPV−, LSIL/HPV−, LSIL/HPV+, HSIL/HPV−, HSIL/HPV+ and cancer cells (SCC/HPV+). We showed for the first time that the glycogen content in the cytoplasm decreased with the nucleus size of cervical cells in all studied groups apart from the cancer group. For the subpopulation of large-nucleus cells HPV infection resulted in considerable glycogen depletion compared to HPV negative cells in IIa, LSIL (for both statistical significance, ca. 45%) and HSIL (trend, 37%) groups. We hypothesize that accelerated glycogenolysis in large-nucleus cells may be associated with the increased protein metabolism for HPV positive cells. Our work underlines unique capabilities of Raman microscopy in single cell studies and demonstrate potential of Raman-based methods in HPV diagnostics.

human papillomavirus
glycogen
cervical cancer
cervical dysplasia
Raman microscopy
glycogenolysis

Please wait, diff process is still running!

References

Cirkel, C.; Barop, C.; Beyer, D.A; Method comparison between Munich II and III nomenclature for Pap smear samples. Geburtshilfe und Frauenheilkunde 2015, 16, 203–207.
Curtis, M.; Kenny, H.A.; Ashcroft, B.; Salomon, A.R.; Nebreda, A.R.; Lengyel, E; Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019, 29, 141–155.e9, 10.3410/f.733939084.793550365.
Hervieu, A.; Kermorgant, S; The Role of PI3K in Met Driven Cancer: A Recap. Front. Mol. Biosci. 2018, 5, 86, 10.3389/fmolb.2018.00086.
Zink, D.; Fischer, A.H.; Nickerson, J.A; Nuclear structure in cancer cells. Nat. Rev. Cancer 2004, 4, 677–687.
Sørensen, F.B.; Bichel, P.; Jakobsen, A; DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact. Cancer 1992, 69, 187–199.
Warburg, O; On the origin of cancer cells. Science 1956, 123, 309–314.
Christos Zois; Adrian L. Harris; Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy. Journal of Molecular Medicine 2016, 94, 137-54, 10.1007/s00109-015-1377-9.
Sonia C Dolfi; Leo Li-Ying Chan; Jean Qiu; Philip M Tedeschi; Joseph Bertino; Kim M. Hirshfield; Z. N. Oltvai; A Vazquez; The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer & Metabolism 2013, 1, 20, 10.1186/2049-3002-1-20.
Mary C. Thomas; Cheng-Ming Chiang; E6 Oncoprotein Represses p53-Dependent Gene Activation via Inhibition of Protein Acetylation Independently of Inducing p53 Degradation. Molecular Cell 2005, 17, 251-264, 10.1016/j.molcel.2004.12.016.
Daeyoup Lee; Chunghun Lim; Taegun Seo; Hyockman Kwon; Hyesun Min; J Choe; The Viral Oncogene Human Papillomavirus E7 Deregulates Transcriptional Silencing by Brm-related Gene 1 via Molecular Interactions. Journal of Biological Chemistry 2002, 277, 48842-48848, 10.1074/jbc.m203583200.
Rodríguez-García, A.; Samsó, P.; Fontova, P.; Simon-Molas, H.; Manzano, A.; Castano, E.; Rosa, J.L.; Martinez-Outshoorn, U.; Ventura, F.; Navarro-Sabate, A.; et al. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells. FEBS J. 2017, 284, 3437–3454.